Agentic Clinical Intelligence Platform (ACIP)

Agentic Clinical Intelligence Platform (ACIP)

1. Background and Context
   Generative AI (GenAI) offers transformative potential in healthcare but faces major challenges: hallucinations, data quality/bias issues, high costs and unclear ROI, integration difficulties, privacy/security risks, lack of transparency, governance gaps, and adoption barriers. Wearable digital health technologies enable continuous physiological monitoring; AI-ECG systems improve accuracy and efficiency when designed for human–AI collaboration; and ambient GenAI tools can reduce documentation burden. These capabilities remain siloed. A unified, robust software architecture is needed to orchestrate them safely and effectively.

2. Project Vision
   Develop and validate a service-oriented multi-agent software architecture that orchestrates wearable data streams, AI-assisted ECG interpretation (with strong human–AI collaboration), and GenAI-powered clinical documentation into a cohesive, clinician-centered clinical decision-support and workflow system. The platform explicitly addresses GenAI challenges through human-in-the-loop design, governance, observability, and trustworthiness mechanisms.

3. Primary Objectives
   • Design and implement a service-oriented multi-agent architecture (aligned with Agentic Service-Oriented Computing principles) in which specialized agents handle wearable data ingestion/processing, ECG analysis, documentation generation, clinical reasoning support, and governance/oversight.
   • Integrate continuous wearable physiological data with AI-driven ECG analysis that prioritizes human–AI collaboration (uncertainty-aware outputs, set-valued predictions, explanations, and clinician override/feedback loops).
   • Deploy ambient/GenAI clinical documentation capabilities that generate high-quality draft notes, summaries, and coding suggestions, with mandatory clinician review and clear accountability.
   • Embed technical and organizational safeguards that mitigate core GenAI risks (reliability, bias, privacy, cost control, transparency, and adoption).
   • Evaluate the integrated system in realistic clinical workflows for impact on diagnostic accuracy, documentation efficiency, clinician workload/burnout, patient safety, and operational productivity.

4. Scope
   In scope: Multi-agent service architecture (independent, composable services with clear APIs, discovery, orchestration, and lifecycle management); integration of selected wearable devices (ECG-capable patches/watches, continuous vital-sign sensors); human–AI collaborative ECG analysis module (building on SHAPE-style closed-loop concepts); ambient GenAI documentation pipeline with clinician review/edit workflow and EHR integration; governance, observability, audit, and human-oversight layers; pilot evaluation in cardiology outpatient/inpatient or remote monitoring settings.

Out of scope (initial phase): Full autonomous decision-making without human oversight; broad multi-disease coverage beyond cardiovascular focus; large-scale multi-center deployment or commercial productization.

5. Key Components / Work Packages
   WP1 – Architecture & Platform: Service-oriented multi-agent framework, orchestration, interoperability, security, and observability.
   WP2 – Wearable Integration: Secure data pipelines, signal processing, quality control, and real-time fusion.
   WP3 – Human–AI ECG Collaboration: Model development, uncertainty quantification, explanation interfaces, feedback loops, and workflow embedding.
   WP4 – GenAI Documentation: Ambient capture, structured note generation, coding support, version control, and mandatory human sign-off.
   WP5 – Governance, Safety & Trust: Hallucination/bias mitigation, privacy techniques, audit trails, policy enforcement, and clinician training.
   WP6 – Evaluation & Iteration: Clinical pilot, quantitative/qualitative metrics, and continuous improvement via real-world feedback.

6. Expected Outcomes and Deliverables
   • Reference architecture and implementation of the multi-agent platform.
   • Working prototype integrating the three core clinical capabilities.
   • Documented governance framework and GenAI-specific risk-mitigation strategies.
   • Pilot study results showing measurable improvements in accuracy, efficiency, and clinician experience while maintaining or enhancing safety.
   • Guidelines and lessons learned for broader adoption of agentic AI systems in digital health.

7. Key Challenges and Mitigation Approach
   The project treats GenAI challenges as first-class design constraints: mandatory human oversight, uncertainty-aware outputs, rigorous data governance, cost-aware architecture, continuous monitoring, and change-management support for clinical users.